World Vaccine Congress Europe 2026 brought together 140 exhibiting companies from 17 countries. The countries with the most exhibitors were Germany (10), United States (8), Spain (6) and Belgium (4). By sector, the largest group was Biotech (50).
Vaccine R&D and manufacturing face rapid technical and commercial shifts that require closer ties between industry, public health and biotech. In mid-October 2026 Amsterdam hosts a focused meeting covering that value chain.
Dates and venue in Amsterdam
World Vaccine Congress Europe 2026 runs from 16 to 19 October 2026 at the RAI International Exhibition and Congress Centre. The schedule includes conference days, exhibition halls and parallel activities aimed at vaccine development, manufacture and supply.
Exhibitors and attendee profile
The event brings together providers of bioprocess equipment, clinical development companies, pharmaceutical manufacturers and public health stakeholders. The organizer lists more than 150 exhibitors and roughly 2,000 attendees, spanning vendors of formulation, cold chain logistics and clinical trial intelligence platforms.
Programme highlights and speaker lineup
Topics range from preclinical research and clinical trials to bioprocessing and cancer immunotherapy. Confirmed speakers include Melanie Saville from PATH, Kate O’Brien from WHO and Maria Elena Bottazzi from Baylor College of Medicine. Sessions address supply and access, pandemic preparedness and immune profiling for next-generation vaccines.
Key figures for commercial planning
Published figures note 150 plus exhibitors, approximately 2,000 attendees and about 280 speakers. The congress features one-to-one partnering and a significant volume of networking connections, which helps structure outreach plans ahead of arrival in Amsterdam.
Practical prospecting advice for World Vaccine Congress Europe 2026
-
Set specific commercial targets and segment prospects by technical area. Prioritize bioprocess leads for scale-up offerings and clinical development contacts for trial-related services.
-
Bring concise technical dossiers. Conversations are technical and time-limited. Prepare validation summaries, scale metrics and clinical use cases.
-
Book one-to-one meetings in advance and use exhibition time for hands-on demonstrations. When possible, obtain attendee lists by role to pre-filter high-value contacts.
-
Field team composition matters. Deploy at least one technical expert and one commercial lead to address scientific questions and move commercial steps forward.
-
Execute immediate follow-up with measurable next steps. Define the follow-up action for each meeting whether a protocol send, remote demo or technical proposal.
What to prioritise on the show floor and in sessions
On the floor, focus on cleanroom suppliers, lyophilization systems and cold chain technologies. In sessions, target talks on therapeutic vaccines and platform technologies that could require co-development or licensing. Partnership and access tracks are useful to spot regional market-entry partners.
Closing note and how to register
For companies offering process equipment, clinical trial services or supply solutions, World Vaccine Congress Europe 2026 is an opportunity to benchmark offers in front of regulators and buyers. Registration, sponsorship and the full agenda are available at the official site http://www.terrapinn.com/conference/world-vaccine-congress-europe
Imágenes
Registration and tickets on the official website: secure.terrapinn.com
